1. Home
  2. IMMR vs AVXL Comparison

IMMR vs AVXL Comparison

Compare IMMR & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immersion Corporation

IMMR

Immersion Corporation

N/A

Current Price

$7.40

Market Cap

215.8M

Sector

Technology

ML Signal

N/A

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

N/A

Current Price

$2.87

Market Cap

237.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IMMR
AVXL
Founded
1993
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
215.8M
237.2M
IPO Year
1999
2013

Fundamental Metrics

Financial Performance
Metric
IMMR
AVXL
Price
$7.40
$2.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$13.50
$22.00
AVG Volume (30 Days)
442.0K
898.5K
Earning Date
04-13-2026
05-08-2026
Dividend Yield
5.11%
N/A
EPS Growth
N/A
N/A
EPS
0.14
N/A
Revenue
$35,013,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$54.14
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.25
$2.26
52 Week High
$8.05
$10.40

Technical Indicators

Market Signals
Indicator
IMMR
AVXL
Relative Strength Index (RSI) 49.37 43.98
Support Level $6.30 $2.62
Resistance Level $7.84 $3.63
Average True Range (ATR) 0.18 0.18
MACD -0.04 -0.08
Stochastic Oscillator 21.67 8.65

Price Performance

Historical Comparison
IMMR
AVXL

About IMMR Immersion Corporation

Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: